| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 31 Jan 2026 | 23 Jan 2026 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2025. With reference to the notice of Board Meeting dated January 23, 2026, we hereby inform that the Board of Directors at its Meeting held on January 31, 2026 has inter-alia approved the following : 1) Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2025 2) Collaboration of the Company with a developer for setting up of a Group Captive Wind Power Plant through a Special Purpose Vehicle company (SPV) and the Company along with other consumers, if any, to invest in up to 26% equity stake in the proposed SPV as a Captive User for the said electricity power Advanced Enzyme Technologies Limited has informed the Exchange about the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended December 31, 2025 Approved collaboration of the Company with a developer for setting up of a Group captive Wind Power Plant through a Special Purpose Vechile Company (SPV) and the Company along with other consumers, if any, to invest in upto 26% equity stake in the proposed SPV as a Captive User for the said electricity power. (As Per BSE Announcement Dated on 31.01.2026) | ||
| Board Meeting | 12 Nov 2025 | 4 Nov 2025 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Un-Audited Standalone And Consolidated Financial Results for the Quarter and Half Year ended 30 September 2025 Please find enclosed herewith the unaudited financial results of the Company for the quarter and half year ended September 30, 2025 along with the Limited review report. (As Per BSE Announcement Dated on: 12/11/2025) | ||
| Board Meeting | 2 Aug 2025 | 25 Jul 2025 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 inter alia to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2025. With reference to the notice of Board Meeting dated July 25, 2025, we hereby inform that the Board of Directors at its Meeting held on August 02, 2025 (commenced at 11.10 a.m. and concluded at 11.40 a.m.) has inter alia, transacted the following business: 1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2025. 2) Approved an investment of ? 10 million in the Equity Shares of Advanced Nutrazyme Private Limited, an existing Wholly Owned Subsidiary. (As Per BSE Announcement Dated on: 02.08.2025) | ||
| Board Meeting | 13 May 2025 | 6 May 2025 |
| Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2025 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 13 2025 inter alia to consider the following: 1) To consider & approve annual Financial Statements (Standalone & Consolidated) of the Company for the financial year ended March 31 2025 along with results of the fourth quarter; 2) To consider & recommend Final dividend if any for the financial year ended March 31 2025 and/or to consider & declare Interim Dividend if any for the financial year ended March 31 2026. Please refer to the attached file. (As Per BSE Announcement Dated on:13.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
